FARRAGUT PARTNERS LLP

Lobbying for PIERRE FABRE PHARMACEUTICALS, INC. · Pharmaceuticals

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to FDA coverage of Tabelecucel

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem